BE
BE · BE · BE-AMP-SAM661618-00
Briumvi 150 mg
ATC L04AG14
Last synced from FAMHP / AFMPS (Belgium) on
Identification
ManufacturerNeuraxpharm Pharmaceuticals
CountryBE (BE)
ATC codeL04AG14
Dispensing—
ReimbursedNo
SourceFAMHP / AFMPS (Belgium)
Last synced6/13/2026
Packs · 2
- be_apb4901724
- be_apb7742877
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Concentrate for solution for infusion",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Briumvi 150 mg",
"name_fr": "Briumvi 150 mg",
"name_nl": "Briumvi 150 mg",
"amp_code": "SAM661618-00",
"strengths": [
"25.0000",
"25.0000",
"25.0000"
],
"pack_count": 3,
"substances": [
"Ublituximab"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Ublituximab",
"authorisation_numbers": [
"EU/1/23/1730/001",
"EU/1/23/1730/002"
]
}Related drugs
Other records sharing ATC code L04AG14.
Access this data programmatically
Query Briumvi 150 mg and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.